BACKGROUND: To study the impact of the dietary antioxidant quercetin on risk of gastric adenocarcinoma. PATIENTS AND METHODS: Using data from a large Swedish population-based case-control study of gastric cancer (505 cases and 1116 controls), we studied the association between quercetin and risk of anatomic (cardia/noncardia) and histological (intestinal and diffuse) subtypes of gastric cancer. RESULTS: We found strong inverse associations between quercetin and the risk of noncardia gastric adenocarcinoma, with an adjusted odds ratio (OR) of 0.57 (95% confidence interval 0.40-0.83) for the highest quintile (≥11.9 mg) of daily quercetin intake relative to the lowest quintile of intake (<4 mg quercetin/day), supported by a significant decreasing linear trend (P value < 0.001). Similar findings were observed for the intestinal and diffuse subtype. For cardia cancer, we found a less evident and nonsignificant inverse relationship. The protection of quercetin appeared to be stronger among female smokers, with the OR leveled of at values <0.2 in quintiles 3-5 (>6 mg quercetin/day). CONCLUSIONS: High dietary quercetin intake is inversely related to the risk of noncardia gastric adenocarcinoma, and the protection appears to be particularly strong for women exposed to oxidative stress, such as tobacco smoking.
BACKGROUND: To study the impact of the dietary antioxidant quercetin on risk of gastric adenocarcinoma. PATIENTS AND METHODS: Using data from a large Swedish population-based case-control study of gastric cancer (505 cases and 1116 controls), we studied the association between quercetin and risk of anatomic (cardia/noncardia) and histological (intestinal and diffuse) subtypes of gastric cancer. RESULTS: We found strong inverse associations between quercetin and the risk of noncardia gastric adenocarcinoma, with an adjusted odds ratio (OR) of 0.57 (95% confidence interval 0.40-0.83) for the highest quintile (≥11.9 mg) of daily quercetin intake relative to the lowest quintile of intake (<4 mg quercetin/day), supported by a significant decreasing linear trend (P value < 0.001). Similar findings were observed for the intestinal and diffuse subtype. For cardia cancer, we found a less evident and nonsignificant inverse relationship. The protection of quercetin appeared to be stronger among female smokers, with the OR leveled of at values <0.2 in quintiles 3-5 (>6 mg quercetin/day). CONCLUSIONS: High dietary quercetin intake is inversely related to the risk of noncardia gastric adenocarcinoma, and the protection appears to be particularly strong for women exposed to oxidative stress, such as tobacco smoking.
Authors: N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper Journal: N Engl J Med Date: 2001-09-13 Impact factor: 91.245
Authors: Gladys Block; Christopher D Jensen; Jason D Morrow; Nina Holland; Edward P Norkus; Ginger L Milne; Mark Hudes; Tapashi B Dalvi; Patricia B Crawford; Ellen B Fung; Laurie Schumacher; Paul Harmatz Journal: Free Radic Biol Med Date: 2008-04-16 Impact factor: 7.376
Authors: Lucy Sun; Amy F Subar; Claire Bosire; Sanford M Dawsey; Lisa L Kahle; Thea P Zimmerman; Christian C Abnet; Ruth Heller; Barry I Graubard; Michael B Cook; Jessica L Petrick Journal: J Nutr Date: 2017-07-19 Impact factor: 4.798
Authors: J L Petrick; S E Steck; P T Bradshaw; K F Trivers; P E Abrahamson; L S Engel; K He; W-H Chow; S T Mayne; H A Risch; T L Vaughan; M D Gammon Journal: Br J Cancer Date: 2015-03-31 Impact factor: 7.640
Authors: Christian Busch; Markus Burkard; Christian Leischner; Ulrich M Lauer; Jan Frank; Sascha Venturelli Journal: Clin Epigenetics Date: 2015-07-10 Impact factor: 6.551